Sequences from Piscirickettsia salmonis

Details Sequences from Piscirickettsia salmonis Sequences from Piscirickettsia salmonis

2005-05-03

2005-05-03

Graser, Jennifer E. (Department: 1645)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S024320, C536S022100, C435S320100, C435S975000, C435S006120

Reexamination Certificate

active

06887989

ABSTRACT:
The present invention relates to a fish vaccine. More specifically the invention relates to a vaccine to protect salmon against infection byPiscirickettsia salmonis. The invention is based on or derived from the nucleic acid or amino acid sequence of antigens fromPiscirickettsia salmonis. Nucleic acid and/or amino acid sequences may be used in the preparation of a vaccine to protect against infection byPiscirickettsia salmonis.

REFERENCES:
patent: 20030165526 (2003-09-01), Kuzyk et al.
patent: 2381708 (2002-04-01), None
patent: 2 356 632 (2001-05-01), None
Henriquez et al. Gencore Accession No. AY256822. Aug. 27, 2001.*
Tosco et al. Gencore Accession No. AJ43594. Jul. 12, 1999.*
Barnes et al., “Purification ofPiscirickettsia salmonisand partial characterization of antigens”, Diseases of Aquatic Organisms, vol. 33(1) , pp. 33-41, (1998).
Jones et al., “Virulence and antigenic characteristics of a cultured Rickettsiales-like organism isolated from farmed Atlantic salmon Salmo salar in eastern Canada”, Disease of Aquatic Organisms, vol. 33(1), pp. 25-31, (1998).
Kuzyk et al., “OspA, a Lipoprotein Antigen of the Obligate Intracellular Bacterial PathogenPiscirickettsia salmonis”, J. Mol. Microbiol. Biotechnol., vol. 3(1), pp. 83-93, (2001).
Marshall et al., “Minimally Invasive Detection ofPiscirickettsia salmonisin Cultivated Salmonids via the PCR”, Applied and Environmental Microbiology, vol. 64(8), pp. 3066-3069, (Aug. 1998).
Goh et al., “HSP60 Gene Sequences as Universal Targets for Microbial Species Identification: Studies with Coagulase-Negative Staphylococci”, J. Clin. Microbiol., vol. 34, No. 4, pp. 818-823, (Apr. 1996).
Kohler et al., “Continuous cultures of fused cells secreting antibody of predefined specificity”, Nature, vol. 256, pp. 495-497, (Aug. 7, 1975).
Smith et al., “Single-step purification of polypeptides expressed inEscherichia colias fusions with glutathione S-transferase”, Gene, vol. 67, pp. 31-40, (1988).
Triglia et al., “A procedure for in vitro amplification of DNA segments that lie outside the boundries of known sequences”, Nucl. Acids Res., vol. 16, No. 16, pp. 8186, (1988).
Henriquez et al. GenBank Deposit Accession No. AY256822, dated May 12, 2003.
Kuzyk et al.,J. Mol. Microbiol. Biotechno. 3(1):83-93, 2001.
Kuzyk et al.,Vaccine19:2337-2344, 2001.
Genbank Accession No. AF184152, submitted Sep. 10, 1999.
Millennium Second World Congress on Vaccines and Immunizations, Liége, Belgium, Aug. 29, 2000 through Sep. 3, 2000, see Workshop 11, p. 22.
U.S. patent application Publication No. U.S. 2003/0147909 A1, publication date: Aug. 7, 2003, Sergio Herman Marshall Gonzalez, “Highly Immunogenic Protein Against the Intracelluar Pathogen . . . ”.

Affiliated with

Also associated with

Rating

Sequences from Piscirickettsia salmonis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sequences from Piscirickettsia salmonis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequences from Piscirickettsia salmonis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3440062